Human Genome Epidemiology Literature Finder
|
Records 1 - 24 (of 24 Records) |
| Query Trace: Recurrence and ABCB1[original query] |
|---|
| Multidrug-resistant genotype (ABCB1) and seizure recurrence in newly treated epilepsy: data from international pharmacogenetic cohorts. Epilepsia 2009 Jul 50 (7): 1689-96. Szoeke Cassandra, Sills Graeme J, Kwan Patrick, Petrovski Slave, Newton Mark, Hitiris Nikolas, Baum Larry, Berkovic Samuel F, Brodie Martin J, Sheffield Leslie J, O'Brien Terence |
| Polymorphisms in ABCB1 and ERCC2 associated with ovarian cancer outcome. International journal of molecular epidemiology and genetics 2011 2 (2): 185-95. Peethambaram Prema, Fridley Brooke L, Vierkant Robert A, Larson Melissa C, Kalli Kimberly R, Elliott Elaine A, Oberg Ann L, White Kristin L, Rider David N, Keeney Gary L, Cunningham Julie M, Hartmann Lynn C, Goode Ellen |
| The risk of recurrence in breast cancer patients treated with tamoxifen: polymorphisms of CYP2D6 and ABCB1. The AAPS journal 2012 Mar 14 (1): 52-9. Teh L K, Mohamed N I, Salleh M Z, Rohaizak M, Shahrun N S, Saladina J J, Shia J K S, Roslan H, Sood S, Rajoo T S, Muniandy S P, Henry G, Ngow H A, Hla U K T, Din |
| Association of CYP3A4/5, ABCB1 and ABCC2 polymorphisms and clinical outcomes of Thai breast cancer patients treated with tamoxifen. Pharmacogenomics and personalized medicine 2013 6 93-8. Sensorn Insee, Sirachainan Ekaphop, Chamnanphon Montri, Pasomsub Ekawat, Trachu Narumol, Supavilai Porntip, Sukasem Chonlaphat, Pinthong Daraw |
| Association of ABCB1 genetic polymorphisms with susceptibility to colorectal cancer and therapeutic prognosis. Pharmacogenomics 2013 Jun 14 (8): 897-911. Wu Huizhe, Kang Hui, Liu Yong, Xiao Qinghuan, Zhang Yining, Sun Mingjun, Liu Duo, Wang Zhe, Zhao Haishan, Yao Weifan, Jia Tianhong, Wang Enhua, Zheng Zhihong, Wei Minj |
| Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2013 May 22 (5): 987-92. White Kristin L, Vierkant Robert A, Fogarty Zachary C, Charbonneau Bridget, Block Matthew S, Pharoah Paul D P, Chenevix-Trench Georgia, , Rossing Mary Anne, Cramer Daniel W, Pearce Celeste Leigh, Schildkraut Joellen M, Menon Usha, Kjaer Susanne Kruger, Levine Douglas A, Gronwald Jacek, Culver Hoda Anton, Whittemore Alice S, Karlan Beth Y, Lambrechts Diether, Wentzensen Nicolas, Kupryjanczyk Jolanta, Chang-Claude Jenny, Bandera Elisa V, Hogdall Estrid, Heitz Florian, Kaye Stanley B, Fasching Peter A, Campbell Ian, Goodman Marc T, Pejovic Tanja, Bean Yukie, Lurie Galina, Eccles Diana, Hein Alexander, Beckmann Matthias W, Ekici Arif B, Paul James, Brown Robert, Flanagan James M, Harter Philipp, du Bois Andreas, Schwaab Ira, Hogdall Claus K, Lundvall Lene, Olson Sara H, Orlow Irene, Paddock Lisa E, Rudolph Anja, Eilber Ursula, Dansonka-Mieszkowska Agnieszka, Rzepecka Iwona K, Ziolkowska-Seta Izabela, Brinton Louise, Yang Hannah, Garcia-Closas Montserrat, Despierre Evelyn, Lambrechts Sandrina, Vergote Ignace, Walsh Christine, Lester Jenny, Sieh Weiva, McGuire Valerie, Rothstein Joseph H, Ziogas Argyrios, Lubinski Jan, Cybulski Cezary, Menkiszak Janusz, Jensen Allan, Gayther Simon A, Ramus Susan J, Gentry-Maharaj Aleksandra, Berchuck Andrew, Wu Anna H, Pike Malcolm C, Van Denberg David, Terry Kathryn L, Vitonis Allison F, Doherty Jennifer A, Johnatty Sharon E, Defazio Anna, Song Honglin, Tyrer Jonathan, Sellers Thomas A, Phelan Catherine M, Kalli Kimberly R, Cunningham Julie M, Fridley Brooke L, Goode Ellen |
| A systematic review and meta-analysis of somatic and germline DNA sequence biomarkers of esophageal cancer survival, therapy response and stage. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2015 Apr 26 (4): 624-44. Findlay J M, Middleton M R, Tomlinson |
| Impact of genetic variability and treatment-related factors on outcome in early breast cancer patients receiving (neo-) adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide, and docetaxel. Breast cancer research and treatment 2014 Oct 147 (3): 557-70. Vulsteke C, Pfeil A M, Schwenkglenks M, Pettengell R, Szucs T D, Lambrechts D, Peeters M, van Dam P, Dieudonné A S, Hatse S, Neven P, Paridaens R, Wildiers |
| Inherited variation in the ATP-binding cassette transporter ABCB1 and survival after chemotherapy for stage III-IV lung cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2014 Sep 9 (9): 1264-71. Weissfeld Joel L, Diergaarde Brenda, Nukui Tomoko, Buch Shama, Pennathur Arjun, Socinski Mark A, Siegfried Jill M, Romkes Marjor |
| Both PON1 Q192R and CYP2C19*2 influence platelet response to clopidogrel and ischemic events in Chinese patients undergoing percutaneous coronary intervention. International journal of clinical and experimental medicine 2015 8 (6): 9266-74. Chen Yu, Huang Xiaohong, Tang Yong, Xie Yuquan, Zhang Yach |
| Influence of Donor and Recipient CYP3A4, CYP3A5, and ABCB1 Genotypes on Clinical Outcomes and Nephrotoxicity in Liver Transplant Recipients. Transplantation 2016 Oct 100 (10): 2129-2137. Debette-Gratien Marilyne, Woillard Jean-Baptiste, Picard Nicolas, Sebagh Mylène, Loustaud-Ratti Véronique, Sautereau Denis, Samuel Didier, Marquet Pier |
| Identification of genetic variants in pharmacokinetic genes associated with Ewing Sarcoma treatment outcome. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2016 Jun . Ruiz-Pinto S, Pita G, Patiño-García A, García-Miguel P, Alonso J, Pérez-Martínez A, Sastre A, Gómez-Mariano G, Lissat A, Scotlandi K, Serra M, Ladenstein R, Lapouble E, Pierron G, Kontny U, Picci P, Kovar H, Delattre O, González-Neira |
| Interaction of CYP2C19, P2Y12, and GPIIIa Variants Associates With Efficacy of Clopidogrel and Adverse Events on Patients With Ischemic Stroke. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2016 May . Yi Xingyang, Wang Yanfen, Lin Jing, Cheng Wen, Zhou Qiang, Wang Ch |
| Polymorphisms in ABCB1 and CYP19A1 genes affect anastrozole plasma concentrations and clinical outcomes in postmenopausal breast cancer patients. British journal of clinical pharmacology 2016 Oct . Gervasini Guillermo, Jara Carlos, Olier Clara, Romero Nuria, Martínez Ruth, Carrillo Juan Anton |
| Effect of CYP3 A4, CYP3 A5 and ABCB1 gene polymorphisms on the clinical efficacy of tacrolimus in the treatment of nephrotic syndrome. BMC pharmacology & toxicology 2018 Apr 19 (1): 14. Li Min, Xu Min, Liu Wei, Gao X |
| The influence of ABCB1 and P2Y12 genetic variants on clinical outcomes in Chinese intracranial artery stenosis patients. Clinical and experimental pharmacology & physiology 2018 Apr . Li Xingang, Jiang Liqun, Sun Shusen, Li Wei, Li Xiaoqing, Miao Zhongrong, Zhao Zhigang, Ma Ni |
| CYP2C19 and ABCB1 genetic polymorphisms correlate with the recurrence of ischemic cardiovascular adverse events after clopidogrel treatment. Journal of clinical laboratory analysis 2018 Jun 32 (5): e22369. Hou Xumin, Han Wenzheng, Gan Qian, Liu Yuan, Fang Wei |
| Association Between ABCB1 Polymorphisms and Outcomes of Clopidogrel Treatment in Patients With Minor Stroke or Transient Ischemic Attack: Secondary Analysis of a Randomized Clinical Trial. JAMA neurology 2019 Feb . Pan Yuesong, Chen Weiqi, Wang Yilong, Li Hao, Johnston S Claiborne, Simon Tabassome, Zhao Xingquan, Liu Liping, Wang David, Meng Xia, Wang Yongjun, |
| Impact of CYP3A4/5 and ABCB1 polymorphisms on tacrolimus exposure and response in pediatric primary nephrotic syndrome. Pharmacogenomics 2019 10 20 (15): 1071-1083. Huang Lingfei, Wang Junyan, Yang Jufei, Zhang Huifen, Ni Yinghua, Zhu Zhengyi, Wang Huijuan, Gao Peng, Wu Yuanyuan, Mao Jianhua, Fang L |
| Predictive pharmacogenetic biomarkers for breast cancer recurrence prevention by simvastatin. Acta oncologica (Stockholm, Sweden) 2020 5 59 (9): 1009-1015. Ahern Thomas P, Damkier Per, Feddersen Søren, Kjærsgaard Anders, Lash Timothy L, Hamilton-Dutoit Stephen, Lythjohan Cathrine Bredal, Ejlertsen Bent, Christiansen Peer M, Cronin-Fenton Deirdre |
| Pharmacogenetic Profiling in High-Risk Soft Tissue Sarcomas Treated with Neoadjuvant Chemotherapy. Journal of personalized medicine 2022 4 12 (4): . Virgili Manrique Anna C, Salazar Juliana, Arranz María Jesús, Bagué Silvia, Orellana Ruth, López-Pousa Antonio, Cerdà Paula, Gracia Isidre, Majercakova Katarina, Peiró Ana, Trullols Laura, Fernández Manuel, Valverde Sandra, Quintana María Jesús, Bell Olga, Artigas-Baleri Alícia, Sebio A |
| Genetic and molecular features of seizure-freedom following surgical resections for focal epilepsy: A pilot study. Frontiers in neurology 2022 10 13 942643. Louis Shreya, Busch Robyn M, Lal Dennis, Hockings Jennifer, Hogue Olivia, Morita-Sherman Marcia, Vegh Deborah, Najm Imad, Ghosh Chaitali, Bazeley Peter, Eng Charis, Jehi Lara, Rotroff Daniel |
| The Effect of the ABCB1(MDR-1) C3435T Polymorphism in Turkish Patients with Aspirin Resistance in Acute Ischemic Stroke. Translational stroke research 2023 7 . Emrah Yurek, Burcu Genc Yavuz, Esra Guzel Tanoglu, Erdem Gurkas, Ibrahim Altundag, Burhanettin Yalcinkaya, Erdal Y?lmaz, Sahin Col |
| Homologous recombination deficiency score is an independent prognostic factor in esophageal squamous cell carcinoma. The journal of pathology. Clinical research 2024 10 10 (6): e70007. Yulu Wang, Bowen Ding, Yunlan Tao, Lingli Huang, Qian Zhu, Chengying Gao, Mingli Feng, Yuchen H |
- Page last reviewed:Feb 1, 2024
- Content source: